From R&D to GMP-compliant production
The rise of the awareness of biotechnology in recent years is accelerating the emergence of new drug candidates of biological origin. But, we also know that, among all the projects that start, only a few end up developing an effective and safe medicine. But completing drug development is by no means the end of the […]
- Posted by Klinea
- On 27 January, 2022
- 0 Comments
- Read More